A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

Winning the patient-centric race

by Chris Zant, Principal, Deloitte Digital, Deloitte Consulting LLP

Digital technology and the pharma-patient relationship

The evolution of digital technology in health care has been truly breathtaking. Once a few devices and apps in the clinical setting seemed revolutionary. We now see a future with a full-scale digital technology uptake with streamlined reimbursement and back office functions as well as ROI measurement.

Read more

Avoiding a flat line when it comes to risk in health care

by John Condrad, Principal, Deloitte & Touche LLP

A look into the ever-changing technological landscape and risks within the health care industry

Over the past 20 years, hardware (medical devices and wearables) as well as software technologies, have grown exponentially in number and have transformed almost every industry including the health care industry.

These technologies harness smartphones,

Read more

Consumers want connected medical devices, but demand for digital experts could put further strains on the talent pool for medtech

by Pedro Arboleda, Managing Director, Deloitte Monitor

This week, my colleagues and I are attending AdvaMed’s annual MedTech Conference. Participants will hear about the latest innovations, such as new digital products that incorporate the latest advances in wireless technology and increasingly powerful computing capabilities for generating clinical and economic insights. But I worry the industry might overlook another important change that is occurring in parallel—the ability to attract the specific digital talent needed to deliver on the promise of connected medical devices.

Read more

How a digital R&D strategy can improve clinical trial innovation and execution

by Dawn Anderson, Managing director, Deloitte Consulting LLP

The Deloitte Center for Health Solutions recently interviewed 43 biopharmaceutical industry stakeholders to explore where the industry sees value and opportunities for using digital technologies in the clinical development process; understand reasons behind the relatively slow pace of digital adoption; and uncover strategies to overcome barriers and accelerate the use of digital in clinical trials.

Read more

Emerging technologies can boost performance in clinical trials

by Greg Reh, Vice Chairman, US and Global Life Sciences Leader, Deloitte LLP

Technology could help biopharmaceutical companies pull more meaningful data from clinical trials and speed cycle times for products in development. Patients could see benefits, too, including higher satisfaction rates and better overall experiences during each phase of the trial. But, given the complexity of institutions and the broader drug environment, adoption has typically been slow and there are challenges ahead.

Read more

Beyond bitcoin: Five possible uses for blockchain in health care

by Greg Reh, Vice Chairman, US and Global Life Sciences Leader, Deloitte LLP

When I bring up blockchain in client meetings, or in dinner conversations, people tend to have one of two reactions. Either they see it as being synonymous with bitcoin and other digital currencies, or they see blockchain as an overhyped technology.

I agree there is a lot of hype swirling around blockchain, and I also agree that this technology likely isn’t going to turn health care on its head.

Read more